TRIM29 is highly overexpressed in many cancers like lung cancer, bladder cancer, colon cancer, ovarian cancer, and multiple myeloma, whereas TRIM19 is associated with t(15;17)(q24;q21) translocation, which is a key driving agent for acute promyelocytic leukaemia (APL) [25]. Here, TRIM29 is linked to cancer.